SORLIS

Company Overview

Snapshot

Founded in July 2023 by Waseem Geraisy and Micha Nisani, SORLIS operates with 1–10 employees. The company has raised $500,000 across one funding round from one investor. In February 2024, SORLIS secured seed funding from Takwin.

Business overview

SORLIS is a Health Tech & Life Sciences company focused on developing solutions for the early detection and prevention of pressure ulcers. The company's core technology aims to identify pressure injuries at their onset, thereby alleviating patient suffering, streamlining medical staff workflows, and reducing healthcare costs. SORLIS serves the healthcare industry, specifically targeting providers with its B2B business model, and operates within the Medical Devices and Diagnostics Devices sectors.

Company Intelligence Q&A

When was SORLIS founded and by whom?

SORLIS was founded in July 2023 by co-founders Waseem Geraisy and Micha Nisani.

What is SORLIS's primary focus in healthcare?

SORLIS is dedicated to transforming healthcare through the early detection and prevention of pressure ulcers, aiming to improve patient care and streamline medical staff workflows.

How much capital has SORLIS raised to date?

SORLIS has raised a total of $500,000 across one funding round.

What is the current product stage of SORLIS?

SORLIS's product is currently in the R&D stage, focusing on developing solutions for early detection and prevention of pressure ulcers.